BRAND_ANALYSIS#MEDTRONICHEALTH & PHARMA#18 OF 26 IN HEALTH & PHARMAALIGNED
Medtronic
· Public · Updated 25 May 2026 11:16 UTC
#594 of 1208 overall by tension · #18 of 26 in Health & Pharma
13Aligned
The Balanced
Analysis
Medtronic at C=55/B=68 with stock declining -6.19% and sentiment at 0.40 shows healthcare's invisibility paradox—saves lives, builds no brand loyalty. Business persists; care doesn't scale.
IN THE NEWS (100 articles this week)
Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain - PR Newswire
Medtronic plans to buy SPR Therapeutics for $650 million to expand pain treatment options - Reuters